 | • レポートコード：MRC308GR10791 • 出版社/出版日：GlobalInfoResearch / 2023年8月 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
GlobalInfoResearchの最新の調査によると、世界の吸入コルチコステロイド装置の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界の吸入コルチコステロイド装置市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。
市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。
本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– 吸入コルチコステロイド装置の成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため
吸入コルチコステロイド装置市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。
種類別セグメント
・ジプロピオン酸ベクロメタゾン、ブデソニド、フルチカゾン吸入粉末、モメタゾン
用途別セグメント
・病院&診療所、学術&研究機関
主要な市場プレーヤー
・Pfizer Inc.、GlaxoSmithKline Plc、Novartis AG、Mylan NV、Teva Pharmaceutical Industries Ltd.、Boehringer Ingelheim International GmbH、AstraZeneca、F. Hoffmann-La Roche Ltd.、Amgen Inc.、Aurobindo Pharma、Sumitomo Corporation
地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）
本調査レポートの内容は計15章あります。
・第1章では、吸入コルチコステロイド装置製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な吸入コルチコステロイド装置メーカーの企業概要、2019年～2022年までの吸入コルチコステロイド装置の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な吸入コルチコステロイド装置メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別吸入コルチコステロイド装置の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までの吸入コルチコステロイド装置の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での吸入コルチコステロイド装置市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および吸入コルチコステロイド装置の産業チェーンを掲載しています。
・第14、15章では、吸入コルチコステロイド装置の販売チャネル、販売業者、顧客、調査結果について説明します。
***** 目次(一部) *****
・市場概要
– 吸入コルチコステロイド装置の概要
– 種類別分析（2018年vs2022年vs2029年）：ジプロピオン酸ベクロメタゾン、ブデソニド、フルチカゾン吸入粉末、モメタゾン
– 用途別分析（2018年vs2022年vs2029年）：病院&診療所、学術&研究機関
– 世界の吸入コルチコステロイド装置市場規模・予測
– 世界の吸入コルチコステロイド装置生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Pfizer Inc.、GlaxoSmithKline Plc、Novartis AG、Mylan NV、Teva Pharmaceutical Industries Ltd.、Boehringer Ingelheim International GmbH、AstraZeneca、F. Hoffmann-La Roche Ltd.、Amgen Inc.、Aurobindo Pharma、Sumitomo Corporation
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：ジプロピオン酸ベクロメタゾン、ブデソニド、フルチカゾン吸入粉末、モメタゾン
・用途別分析2018年-2029年：病院&診療所、学術&研究機関
・吸入コルチコステロイド装置の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・吸入コルチコステロイド装置のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・吸入コルチコステロイド装置のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・吸入コルチコステロイド装置の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・吸入コルチコステロイド装置の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
1 Market Overview
1.1 Product Overview and Scope of Inhaler Corticosteroid Device
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Inhaler Corticosteroid Device Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Beclomethasone Dipropionate
1.3.3 Budesonide
1.3.4 Fluticasone Inhaler Powder
1.3.5 Mometasone
1.4 Market Analysis by Application
1.4.1 Overview: Global Inhaler Corticosteroid Device Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals and Clinics
1.4.3 Academic and Research Institutes
1.5 Global Inhaler Corticosteroid Device Market Size & Forecast
1.5.1 Global Inhaler Corticosteroid Device Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Inhaler Corticosteroid Device Sales Quantity (2018-2029)
1.5.3 Global Inhaler Corticosteroid Device Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Pfizer Inc.
2.1.1 Pfizer Inc. Details
2.1.2 Pfizer Inc. Major Business
2.1.3 Pfizer Inc. Inhaler Corticosteroid Device Product and Services
2.1.4 Pfizer Inc. Inhaler Corticosteroid Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Pfizer Inc. Recent Developments/Updates
2.2 GlaxoSmithKline Plc
2.2.1 GlaxoSmithKline Plc Details
2.2.2 GlaxoSmithKline Plc Major Business
2.2.3 GlaxoSmithKline Plc Inhaler Corticosteroid Device Product and Services
2.2.4 GlaxoSmithKline Plc Inhaler Corticosteroid Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 GlaxoSmithKline Plc Recent Developments/Updates
2.3 Novartis AG
2.3.1 Novartis AG Details
2.3.2 Novartis AG Major Business
2.3.3 Novartis AG Inhaler Corticosteroid Device Product and Services
2.3.4 Novartis AG Inhaler Corticosteroid Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Novartis AG Recent Developments/Updates
2.4 Mylan NV
2.4.1 Mylan NV Details
2.4.2 Mylan NV Major Business
2.4.3 Mylan NV Inhaler Corticosteroid Device Product and Services
2.4.4 Mylan NV Inhaler Corticosteroid Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Mylan NV Recent Developments/Updates
2.5 Teva Pharmaceutical Industries Ltd.
2.5.1 Teva Pharmaceutical Industries Ltd. Details
2.5.2 Teva Pharmaceutical Industries Ltd. Major Business
2.5.3 Teva Pharmaceutical Industries Ltd. Inhaler Corticosteroid Device Product and Services
2.5.4 Teva Pharmaceutical Industries Ltd. Inhaler Corticosteroid Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
2.6 Boehringer Ingelheim International GmbH
2.6.1 Boehringer Ingelheim International GmbH Details
2.6.2 Boehringer Ingelheim International GmbH Major Business
2.6.3 Boehringer Ingelheim International GmbH Inhaler Corticosteroid Device Product and Services
2.6.4 Boehringer Ingelheim International GmbH Inhaler Corticosteroid Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Boehringer Ingelheim International GmbH Recent Developments/Updates
2.7 AstraZeneca
2.7.1 AstraZeneca Details
2.7.2 AstraZeneca Major Business
2.7.3 AstraZeneca Inhaler Corticosteroid Device Product and Services
2.7.4 AstraZeneca Inhaler Corticosteroid Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 AstraZeneca Recent Developments/Updates
2.8 F. Hoffmann-La Roche Ltd.
2.8.1 F. Hoffmann-La Roche Ltd. Details
2.8.2 F. Hoffmann-La Roche Ltd. Major Business
2.8.3 F. Hoffmann-La Roche Ltd. Inhaler Corticosteroid Device Product and Services
2.8.4 F. Hoffmann-La Roche Ltd. Inhaler Corticosteroid Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates
2.9 Amgen Inc.
2.9.1 Amgen Inc. Details
2.9.2 Amgen Inc. Major Business
2.9.3 Amgen Inc. Inhaler Corticosteroid Device Product and Services
2.9.4 Amgen Inc. Inhaler Corticosteroid Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Amgen Inc. Recent Developments/Updates
2.10 Aurobindo Pharma
2.10.1 Aurobindo Pharma Details
2.10.2 Aurobindo Pharma Major Business
2.10.3 Aurobindo Pharma Inhaler Corticosteroid Device Product and Services
2.10.4 Aurobindo Pharma Inhaler Corticosteroid Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Aurobindo Pharma Recent Developments/Updates
2.11 Sumitomo Corporation
2.11.1 Sumitomo Corporation Details
2.11.2 Sumitomo Corporation Major Business
2.11.3 Sumitomo Corporation Inhaler Corticosteroid Device Product and Services
2.11.4 Sumitomo Corporation Inhaler Corticosteroid Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Sumitomo Corporation Recent Developments/Updates
3 Competitive Environment: Inhaler Corticosteroid Device by Manufacturer
3.1 Global Inhaler Corticosteroid Device Sales Quantity by Manufacturer (2018-2023)
3.2 Global Inhaler Corticosteroid Device Revenue by Manufacturer (2018-2023)
3.3 Global Inhaler Corticosteroid Device Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Inhaler Corticosteroid Device by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Inhaler Corticosteroid Device Manufacturer Market Share in 2022
3.4.2 Top 6 Inhaler Corticosteroid Device Manufacturer Market Share in 2022
3.5 Inhaler Corticosteroid Device Market: Overall Company Footprint Analysis
3.5.1 Inhaler Corticosteroid Device Market: Region Footprint
3.5.2 Inhaler Corticosteroid Device Market: Company Product Type Footprint
3.5.3 Inhaler Corticosteroid Device Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Inhaler Corticosteroid Device Market Size by Region
4.1.1 Global Inhaler Corticosteroid Device Sales Quantity by Region (2018-2029)
4.1.2 Global Inhaler Corticosteroid Device Consumption Value by Region (2018-2029)
4.1.3 Global Inhaler Corticosteroid Device Average Price by Region (2018-2029)
4.2 North America Inhaler Corticosteroid Device Consumption Value (2018-2029)
4.3 Europe Inhaler Corticosteroid Device Consumption Value (2018-2029)
4.4 Asia-Pacific Inhaler Corticosteroid Device Consumption Value (2018-2029)
4.5 South America Inhaler Corticosteroid Device Consumption Value (2018-2029)
4.6 Middle East and Africa Inhaler Corticosteroid Device Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Inhaler Corticosteroid Device Sales Quantity by Type (2018-2029)
5.2 Global Inhaler Corticosteroid Device Consumption Value by Type (2018-2029)
5.3 Global Inhaler Corticosteroid Device Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Inhaler Corticosteroid Device Sales Quantity by Application (2018-2029)
6.2 Global Inhaler Corticosteroid Device Consumption Value by Application (2018-2029)
6.3 Global Inhaler Corticosteroid Device Average Price by Application (2018-2029)
7 North America
7.1 North America Inhaler Corticosteroid Device Sales Quantity by Type (2018-2029)
7.2 North America Inhaler Corticosteroid Device Sales Quantity by Application (2018-2029)
7.3 North America Inhaler Corticosteroid Device Market Size by Country
7.3.1 North America Inhaler Corticosteroid Device Sales Quantity by Country (2018-2029)
7.3.2 North America Inhaler Corticosteroid Device Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Inhaler Corticosteroid Device Sales Quantity by Type (2018-2029)
8.2 Europe Inhaler Corticosteroid Device Sales Quantity by Application (2018-2029)
8.3 Europe Inhaler Corticosteroid Device Market Size by Country
8.3.1 Europe Inhaler Corticosteroid Device Sales Quantity by Country (2018-2029)
8.3.2 Europe Inhaler Corticosteroid Device Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Inhaler Corticosteroid Device Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Inhaler Corticosteroid Device Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Inhaler Corticosteroid Device Market Size by Region
9.3.1 Asia-Pacific Inhaler Corticosteroid Device Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Inhaler Corticosteroid Device Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Inhaler Corticosteroid Device Sales Quantity by Type (2018-2029)
10.2 South America Inhaler Corticosteroid Device Sales Quantity by Application (2018-2029)
10.3 South America Inhaler Corticosteroid Device Market Size by Country
10.3.1 South America Inhaler Corticosteroid Device Sales Quantity by Country (2018-2029)
10.3.2 South America Inhaler Corticosteroid Device Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Inhaler Corticosteroid Device Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Inhaler Corticosteroid Device Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Inhaler Corticosteroid Device Market Size by Country
11.3.1 Middle East & Africa Inhaler Corticosteroid Device Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Inhaler Corticosteroid Device Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Inhaler Corticosteroid Device Market Drivers
12.2 Inhaler Corticosteroid Device Market Restraints
12.3 Inhaler Corticosteroid Device Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Inhaler Corticosteroid Device and Key Manufacturers
13.2 Manufacturing Costs Percentage of Inhaler Corticosteroid Device
13.3 Inhaler Corticosteroid Device Production Process
13.4 Inhaler Corticosteroid Device Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Inhaler Corticosteroid Device Typical Distributors
14.3 Inhaler Corticosteroid Device Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Inhaler Corticosteroid Device Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Inhaler Corticosteroid Device Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Inc. Major Business
Table 5. Pfizer Inc. Inhaler Corticosteroid Device Product and Services
Table 6. Pfizer Inc. Inhaler Corticosteroid Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Pfizer Inc. Recent Developments/Updates
Table 8. GlaxoSmithKline Plc Basic Information, Manufacturing Base and Competitors
Table 9. GlaxoSmithKline Plc Major Business
Table 10. GlaxoSmithKline Plc Inhaler Corticosteroid Device Product and Services
Table 11. GlaxoSmithKline Plc Inhaler Corticosteroid Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. GlaxoSmithKline Plc Recent Developments/Updates
Table 13. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 14. Novartis AG Major Business
Table 15. Novartis AG Inhaler Corticosteroid Device Product and Services
Table 16. Novartis AG Inhaler Corticosteroid Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Novartis AG Recent Developments/Updates
Table 18. Mylan NV Basic Information, Manufacturing Base and Competitors
Table 19. Mylan NV Major Business
Table 20. Mylan NV Inhaler Corticosteroid Device Product and Services
Table 21. Mylan NV Inhaler Corticosteroid Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Mylan NV Recent Developments/Updates
Table 23. Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table 24. Teva Pharmaceutical Industries Ltd. Major Business
Table 25. Teva Pharmaceutical Industries Ltd. Inhaler Corticosteroid Device Product and Services
Table 26. Teva Pharmaceutical Industries Ltd. Inhaler Corticosteroid Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 28. Boehringer Ingelheim International GmbH Basic Information, Manufacturing Base and Competitors
Table 29. Boehringer Ingelheim International GmbH Major Business
Table 30. Boehringer Ingelheim International GmbH Inhaler Corticosteroid Device Product and Services
Table 31. Boehringer Ingelheim International GmbH Inhaler Corticosteroid Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Boehringer Ingelheim International GmbH Recent Developments/Updates
Table 33. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 34. AstraZeneca Major Business
Table 35. AstraZeneca Inhaler Corticosteroid Device Product and Services
Table 36. AstraZeneca Inhaler Corticosteroid Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. AstraZeneca Recent Developments/Updates
Table 38. F. Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base and Competitors
Table 39. F. Hoffmann-La Roche Ltd. Major Business
Table 40. F. Hoffmann-La Roche Ltd. Inhaler Corticosteroid Device Product and Services
Table 41. F. Hoffmann-La Roche Ltd. Inhaler Corticosteroid Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. F. Hoffmann-La Roche Ltd. Recent Developments/Updates
Table 43. Amgen Inc. Basic Information, Manufacturing Base and Competitors
Table 44. Amgen Inc. Major Business
Table 45. Amgen Inc. Inhaler Corticosteroid Device Product and Services
Table 46. Amgen Inc. Inhaler Corticosteroid Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Amgen Inc. Recent Developments/Updates
Table 48. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 49. Aurobindo Pharma Major Business
Table 50. Aurobindo Pharma Inhaler Corticosteroid Device Product and Services
Table 51. Aurobindo Pharma Inhaler Corticosteroid Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Aurobindo Pharma Recent Developments/Updates
Table 53. Sumitomo Corporation Basic Information, Manufacturing Base and Competitors
Table 54. Sumitomo Corporation Major Business
Table 55. Sumitomo Corporation Inhaler Corticosteroid Device Product and Services
Table 56. Sumitomo Corporation Inhaler Corticosteroid Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Sumitomo Corporation Recent Developments/Updates
Table 58. Global Inhaler Corticosteroid Device Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 59. Global Inhaler Corticosteroid Device Revenue by Manufacturer (2018-2023) & (USD Million)
Table 60. Global Inhaler Corticosteroid Device Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 61. Market Position of Manufacturers in Inhaler Corticosteroid Device, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 62. Head Office and Inhaler Corticosteroid Device Production Site of Key Manufacturer
Table 63. Inhaler Corticosteroid Device Market: Company Product Type Footprint
Table 64. Inhaler Corticosteroid Device Market: Company Product Application Footprint
Table 65. Inhaler Corticosteroid Device New Market Entrants and Barriers to Market Entry
Table 66. Inhaler Corticosteroid Device Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Inhaler Corticosteroid Device Sales Quantity by Region (2018-2023) & (K Units)
Table 68. Global Inhaler Corticosteroid Device Sales Quantity by Region (2024-2029) & (K Units)
Table 69. Global Inhaler Corticosteroid Device Consumption Value by Region (2018-2023) & (USD Million)
Table 70. Global Inhaler Corticosteroid Device Consumption Value by Region (2024-2029) & (USD Million)
Table 71. Global Inhaler Corticosteroid Device Average Price by Region (2018-2023) & (US$/Unit)
Table 72. Global Inhaler Corticosteroid Device Average Price by Region (2024-2029) & (US$/Unit)
Table 73. Global Inhaler Corticosteroid Device Sales Quantity by Type (2018-2023) & (K Units)
Table 74. Global Inhaler Corticosteroid Device Sales Quantity by Type (2024-2029) & (K Units)
Table 75. Global Inhaler Corticosteroid Device Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Global Inhaler Corticosteroid Device Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Global Inhaler Corticosteroid Device Average Price by Type (2018-2023) & (US$/Unit)
Table 78. Global Inhaler Corticosteroid Device Average Price by Type (2024-2029) & (US$/Unit)
Table 79. Global Inhaler Corticosteroid Device Sales Quantity by Application (2018-2023) & (K Units)
Table 80. Global Inhaler Corticosteroid Device Sales Quantity by Application (2024-2029) & (K Units)
Table 81. Global Inhaler Corticosteroid Device Consumption Value by Application (2018-2023) & (USD Million)
Table 82. Global Inhaler Corticosteroid Device Consumption Value by Application (2024-2029) & (USD Million)
Table 83. Global Inhaler Corticosteroid Device Average Price by Application (2018-2023) & (US$/Unit)
Table 84. Global Inhaler Corticosteroid Device Average Price by Application (2024-2029) & (US$/Unit)
Table 85. North America Inhaler Corticosteroid Device Sales Quantity by Type (2018-2023) & (K Units)
Table 86. North America Inhaler Corticosteroid Device Sales Quantity by Type (2024-2029) & (K Units)
Table 87. North America Inhaler Corticosteroid Device Sales Quantity by Application (2018-2023) & (K Units)
Table 88. North America Inhaler Corticosteroid Device Sales Quantity by Application (2024-2029) & (K Units)
Table 89. North America Inhaler Corticosteroid Device Sales Quantity by Country (2018-2023) & (K Units)
Table 90. North America Inhaler Corticosteroid Device Sales Quantity by Country (2024-2029) & (K Units)
Table 91. North America Inhaler Corticosteroid Device Consumption Value by Country (2018-2023) & (USD Million)
Table 92. North America Inhaler Corticosteroid Device Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Europe Inhaler Corticosteroid Device Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Europe Inhaler Corticosteroid Device Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Europe Inhaler Corticosteroid Device Sales Quantity by Application (2018-2023) & (K Units)
Table 96. Europe Inhaler Corticosteroid Device Sales Quantity by Application (2024-2029) & (K Units)
Table 97. Europe Inhaler Corticosteroid Device Sales Quantity by Country (2018-2023) & (K Units)
Table 98. Europe Inhaler Corticosteroid Device Sales Quantity by Country (2024-2029) & (K Units)
Table 99. Europe Inhaler Corticosteroid Device Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe Inhaler Corticosteroid Device Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific Inhaler Corticosteroid Device Sales Quantity by Type (2018-2023) & (K Units)
Table 102. Asia-Pacific Inhaler Corticosteroid Device Sales Quantity by Type (2024-2029) & (K Units)
Table 103. Asia-Pacific Inhaler Corticosteroid Device Sales Quantity by Application (2018-2023) & (K Units)
Table 104. Asia-Pacific Inhaler Corticosteroid Device Sales Quantity by Application (2024-2029) & (K Units)
Table 105. Asia-Pacific Inhaler Corticosteroid Device Sales Quantity by Region (2018-2023) & (K Units)
Table 106. Asia-Pacific Inhaler Corticosteroid Device Sales Quantity by Region (2024-2029) & (K Units)
Table 107. Asia-Pacific Inhaler Corticosteroid Device Consumption Value by Region (2018-2023) & (USD Million)
Table 108. Asia-Pacific Inhaler Corticosteroid Device Consumption Value by Region (2024-2029) & (USD Million)
Table 109. South America Inhaler Corticosteroid Device Sales Quantity by Type (2018-2023) & (K Units)
Table 110. South America Inhaler Corticosteroid Device Sales Quantity by Type (2024-2029) & (K Units)
Table 111. South America Inhaler Corticosteroid Device Sales Quantity by Application (2018-2023) & (K Units)
Table 112. South America Inhaler Corticosteroid Device Sales Quantity by Application (2024-2029) & (K Units)
Table 113. South America Inhaler Corticosteroid Device Sales Quantity by Country (2018-2023) & (K Units)
Table 114. South America Inhaler Corticosteroid Device Sales Quantity by Country (2024-2029) & (K Units)
Table 115. South America Inhaler Corticosteroid Device Consumption Value by Country (2018-2023) & (USD Million)
Table 116. South America Inhaler Corticosteroid Device Consumption Value by Country (2024-2029) & (USD Million)
Table 117. Middle East & Africa Inhaler Corticosteroid Device Sales Quantity by Type (2018-2023) & (K Units)
Table 118. Middle East & Africa Inhaler Corticosteroid Device Sales Quantity by Type (2024-2029) & (K Units)
Table 119. Middle East & Africa Inhaler Corticosteroid Device Sales Quantity by Application (2018-2023) & (K Units)
Table 120. Middle East & Africa Inhaler Corticosteroid Device Sales Quantity by Application (2024-2029) & (K Units)
Table 121. Middle East & Africa Inhaler Corticosteroid Device Sales Quantity by Region (2018-2023) & (K Units)
Table 122. Middle East & Africa Inhaler Corticosteroid Device Sales Quantity by Region (2024-2029) & (K Units)
Table 123. Middle East & Africa Inhaler Corticosteroid Device Consumption Value by Region (2018-2023) & (USD Million)
Table 124. Middle East & Africa Inhaler Corticosteroid Device Consumption Value by Region (2024-2029) & (USD Million)
Table 125. Inhaler Corticosteroid Device Raw Material
Table 126. Key Manufacturers of Inhaler Corticosteroid Device Raw Materials
Table 127. Inhaler Corticosteroid Device Typical Distributors
Table 128. Inhaler Corticosteroid Device Typical Customers
List of Figures
Figure 1. Inhaler Corticosteroid Device Picture
Figure 2. Global Inhaler Corticosteroid Device Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Inhaler Corticosteroid Device Consumption Value Market Share by Type in 2022
Figure 4. Beclomethasone Dipropionate Examples
Figure 5. Budesonide Examples
Figure 6. Fluticasone Inhaler Powder Examples
Figure 7. Mometasone Examples
Figure 8. Global Inhaler Corticosteroid Device Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global Inhaler Corticosteroid Device Consumption Value Market Share by Application in 2022
Figure 10. Hospitals and Clinics Examples
Figure 11. Academic and Research Institutes Examples
Figure 12. Global Inhaler Corticosteroid Device Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Inhaler Corticosteroid Device Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Inhaler Corticosteroid Device Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Inhaler Corticosteroid Device Average Price (2018-2029) & (US$/Unit)
Figure 16. Global Inhaler Corticosteroid Device Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Inhaler Corticosteroid Device Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Inhaler Corticosteroid Device by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Inhaler Corticosteroid Device Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Inhaler Corticosteroid Device Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Inhaler Corticosteroid Device Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Inhaler Corticosteroid Device Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Inhaler Corticosteroid Device Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Inhaler Corticosteroid Device Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Inhaler Corticosteroid Device Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Inhaler Corticosteroid Device Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Inhaler Corticosteroid Device Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Inhaler Corticosteroid Device Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Inhaler Corticosteroid Device Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Inhaler Corticosteroid Device Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global Inhaler Corticosteroid Device Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Inhaler Corticosteroid Device Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Inhaler Corticosteroid Device Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America Inhaler Corticosteroid Device Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Inhaler Corticosteroid Device Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Inhaler Corticosteroid Device Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Inhaler Corticosteroid Device Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Inhaler Corticosteroid Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Inhaler Corticosteroid Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Inhaler Corticosteroid Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Inhaler Corticosteroid Device Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Inhaler Corticosteroid Device Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Inhaler Corticosteroid Device Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Inhaler Corticosteroid Device Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Inhaler Corticosteroid Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Inhaler Corticosteroid Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Inhaler Corticosteroid Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Inhaler Corticosteroid Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Inhaler Corticosteroid Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Inhaler Corticosteroid Device Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Inhaler Corticosteroid Device Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Inhaler Corticosteroid Device Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Inhaler Corticosteroid Device Consumption Value Market Share by Region (2018-2029)
Figure 54. China Inhaler Corticosteroid Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Inhaler Corticosteroid Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Inhaler Corticosteroid Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Inhaler Corticosteroid Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Inhaler Corticosteroid Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Inhaler Corticosteroid Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Inhaler Corticosteroid Device Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Inhaler Corticosteroid Device Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Inhaler Corticosteroid Device Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Inhaler Corticosteroid Device Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Inhaler Corticosteroid Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Inhaler Corticosteroid Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Inhaler Corticosteroid Device Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Inhaler Corticosteroid Device Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Inhaler Corticosteroid Device Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Inhaler Corticosteroid Device Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Inhaler Corticosteroid Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Inhaler Corticosteroid Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Inhaler Corticosteroid Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Inhaler Corticosteroid Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Inhaler Corticosteroid Device Market Drivers
Figure 75. Inhaler Corticosteroid Device Market Restraints
Figure 76. Inhaler Corticosteroid Device Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Inhaler Corticosteroid Device in 2022
Figure 79. Manufacturing Process Analysis of Inhaler Corticosteroid Device
Figure 80. Inhaler Corticosteroid Device Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source